Medicine guide

Teriflunomide Accord

·

  • Prescription status not stated
  • Cancer treatments and immune-system medicines
Active substance
Teriflunomide
Made by
Accord Healthcare S.L.U.

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Teriflunomide Accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (MS) (please refer to section 5.1 for important information on the population for which efficacy has been established).

From the official label · 2026-09-30 · European Medicines Agency

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

United StatesNo exact match for this strength and form

BulgariaNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byAccord Healthcare S.L.U.
Active substanceTeriflunomide
Used inCancer treatments and immune-system medicines
ClassificationL04AK02 · Cancer treatments and immune-system medicines
GenericYes — a generic medicine, according to the register
Authorised on2022-11-09
Last updated by the regulator2026-02-24
EMA product numberEMEA/H/C/005960

Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician

Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.